Entrada Therapeutics, Inc. Balance Sheet
TRDA|3 years of annual SEC 10-K data (FY2023-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
Entrada Therapeutics, Inc. had $377M in total assets and $429M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.03 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash & Equivalents | $90.4M | $101.2M | $67.6M |
| Current Assets | $306.3M | $440.0M | $369.8M |
| PP&E (Net) | $7.3M | $10.9M | $11.2M |
| Total Assets | $377.4M | $526.3M | $469.2M |
| Current Liabilities | $24.5M | $39.5M | $158.8M |
| Shareholders' Equity | $428.7M | $242.4M | $212.6M |